To manage the respiratory distress, skin issues, visual impairments, and
mental challenges presented by the newborn., the decision was made to
admit the baby to the Neonatal Intensive Care Unit (NICU) for
specialized care(figure 2,3). The baby was placed in a
temperature-controlled incubator within this unit to provide the optimal
environment for their recovery and well-being.
A comprehensive regimen of medications and therapies was established for
the baby’s treatment. To alleviate the breathing difficulties, the baby
was administered gentamicin and ampicillin intramuscularly to combat
potential infections. The skin conditions were treated with a
combination of topical medications, including an emulsion of RDen,
mupirocin ointment, Lubratax ointment, erythromycin ointment, and
gentamicin eye ointment. These treatments aim to alleviate skin issues
and promote healing.
In addition to these measures, meticulous eye care was essential due to
visual impairments. Gentamicin eye ointment and injections managed
potential eye infections and protected the baby’s delicate eyesight.
Furthermore, a portable brain ultrasound on the newborn revealed no
evident signs of hydrocephalus or midline shift, providing some relief
from concerns related to these conditions. There were no indications of
intraventricular hemorrhage (IVH) or cerebral parenchymal lesions,
underscoring the importance of early monitoring and intervention to
safeguard the baby’s neurological health. The multidisciplinary approach
in the NICU, combining respiratory support, dermatological care, eye
treatments, and neurological assessments, aimed to provide the newborn
with the best possible care and enhance their prospects for a healthy
future. Close monitoring and tailored interventions will continue to be
essential to the baby’s ongoing care and treatment plan.
Despite all efforts for further investigations and actions to treat the
patient, the baby’s family finally discharged the baby from the hospital
with personal consent.
Discussion :